Cost effectiveness of selective internal radiation therapy (SIRT) with Y-90 resin microspheres versus sorafenib in Barcelona Clinic Liver Cancer (BCLC) stage C hepatocellular carcinoma patients in the UK

被引:0
|
作者
Palmer, D. [1 ]
Ross, P. [2 ,3 ]
Shah, T. [4 ]
Yu, D. [5 ]
Shergill, S. [6 ]
Patterson, K. [7 ]
Brereton, N. [7 ]
Lee, D. [7 ]
机构
[1] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool, Merseyside, England
[2] Guys & St Thomas NHS Fdn Trust, Dept Oncol, London, England
[3] Kings Coll Hosp NHS Fdn Trust, London, England
[4] Queen Elizabeth Hosp Birmingham, Neuroendocrine Tumour Ctr, Birmingham, W Midlands, England
[5] Royal Free Hosp, Dept Radiol, London, England
[6] SIRTEX, Global Pricing Reimbursement & Market Access, London, England
[7] BresMed, Hlth Econ Anal Team, Sheffield, S Yorkshire, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
703P
引用
收藏
页数:2
相关论文
共 50 条
  • [1] COST-UTILITY ANALYIS OF SELECTIVE INTERNAL RADIATION THERAPY (SIRT) WITH Y-90 RESIN MICROSPHERES IN HEPATOCELLULAR CARCINOMA (HCC)
    Muszbek, N.
    Remak, E.
    Evans, R.
    Brennan, V
    Colaone, F.
    Shergill, S.
    VALUE IN HEALTH, 2019, 22 : S452 - S452
  • [2] Cost-utility analysis of selective internal radiation therapy with Y-90 resin microspheres in hepatocellular carcinoma
    Muszbek, Noemi
    Remak, Edit
    Evans, Rachel
    Brennan, Victoria K.
    Colaone, Fabien
    Shergill, Suki
    Mullan, Damian
    Ross, Paul J.
    FUTURE ONCOLOGY, 2021, 17 (09) : 1055 - 1068
  • [3] A BUDGET IMPACT ANALYSIS OF SELECTIVE INTERNAL RADIATION THERAPY USING Y-90 RESIN MICROSPHERES VERSUS ATEZOLIZUMAB-BEVACIZUMAB AS FIRST-LINE THERAPY IN BARCELONA CLINIC LIVER CANCER STAGE C HEPATOCELLULAR CARCINOMA IN ENGLAND
    Pollock, R. F.
    Agirrezabal, I
    Carion, P. L.
    Roe, R.
    Shergill, S.
    Ross, P. J.
    VALUE IN HEALTH, 2022, 25 (12) : S90 - S90
  • [4] Cost-effectiveness of selective internal radiation therapy with Y-90 resin microspheres for intermediate- and advanced-stage hepatocellular carcinoma in Brazil
    Agirrezabal, Ion
    Grillo Junior, Luiz Sergio Pereira
    Nasser, Felipe
    Brennan, Victoria K.
    Bugano, Diogo
    Galastri, Francisco Leonardo
    de Azeredo-da-Silva, Andre Luis F.
    Shergill, Suki
    da Motta-Leal-Filho, Joaquim Mauricio
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 731 - 741
  • [5] SELECTIVE INTERNAL RADIATION THERAPY USING Y-90 RESIN MICROSPHERES VS CONVENTIONAL TRANSARTERIAL CHEMOEMBOLIZATION IN BARCELONA CLINIC LIVER CANCER STAGE B HEPATOCELLULAR CARCINOMA: A BUDGET IMPACT ANALYSIS IN ENGLAND
    Pollock, R. F.
    Agirrezabal, I.
    Carion, P. L.
    Roe, R.
    Shergill, S.
    Ross, P. J.
    VALUE IN HEALTH, 2022, 25 (12) : S123 - S123
  • [6] Cost-Effectiveness Analysis of Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres versus Sorafenib in Advanced Hepatocellular Carcinoma
    Marqueen, K. E.
    Ang, C.
    Mazumdar, M.
    Buckstein, M.
    Ferket, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E402 - E402
  • [7] Selective internal radiation therapy (SIRT) using 90Y-resin microspheres for patients with hepatocellular carcinoma (HCC)
    Sangro, B.
    Boan, J.
    Bilbao, I.
    Cuesta, A. M.
    Rodriguez, J.
    Benito, A.
    Gil, B.
    Inarrairaegui, M.
    Herrero, J. I.
    Quiroga, J.
    Prieto, J.
    LIVER INTERNATIONAL, 2006, 26 : 15 - 16
  • [8] Selective internal radiation therapy across Barcelona Clinic Liver Cancer (BCLC) stages of hepatocellular carcinoma: literature review
    Vigneron, Paul
    Franze, Maria Stella
    Chalaye, Julia
    Tacher, Vania
    Sessa, Anna
    Luciani, Alain
    Kobeiter, Hicham
    Regnault, Helene
    Bejan, Ancuta
    Calderaro, Julien
    Rhaiem, Rami
    Sommacale, Daniele
    Raimondo, Giovanni
    Leroy, Vincent
    Brustia, Raffaele
    Amaddeo, Giuliana
    HEPATOBILIARY SURGERY AND NUTRITION, 2024, 13 (06) : 974 - 990
  • [9] Overall survival and toxicity of Y90 radioembolization for hepatocellular carcinoma patients in Barcelona Clinic Liver Cancer stage C (BCLC-C)
    Goswami, Pulak
    Adeniran, Oladapo R.
    Frantz, Shelby K.
    Matsuoka, Lea
    Du, Liping
    Gandhi, Ripal T.
    Collins, Zachary S.
    Matrana, Marc R.
    Petroziello, Michael
    Brower, Jayson S.
    Sze, Daniel Y.
    Kennedy, Andrew S.
    Golzarian, Jafar
    Wang, Eric A.
    Brown, Daniel B.
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [10] Overall survival and toxicity of Y90 radioembolization for hepatocellular carcinoma patients in Barcelona Clinic Liver Cancer stage C (BCLC-C)
    Pulak Goswami
    Oladapo R. Adeniran
    Shelby K. Frantz
    Lea Matsuoka
    Liping Du
    Ripal T. Gandhi
    Zachary S. Collins
    Marc R. Matrana
    Michael Petroziello
    Jayson S. Brower
    Daniel Y. Sze
    Andrew S. Kennedy
    Jafar Golzarian
    Eric A. Wang
    Daniel B. Brown
    BMC Gastroenterology, 22